医療関係者の方へ 診療科案内

ホームへ戻る

肝臓・胆道・膵臓英論文

2022

  1. Needle tract seeding after endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: A nationwide survey in Japan
    Kitano M, Yoshida M, Ashida R, Kita E, Katanuma A, Itoi T, Mikata R, Nishikawa K, Matsubayashi H, Takayama Y, kato H, Takenaka M, Ukeki T, Kawashima Y, Nakai Y, Hashimoto S, Shigekawa M, Nebiki H, Tsumura H, Okabe Y, Ryozawa S, Harada Y, Mitoro A, Sasaki T, Yasuda H, Miura N, Ikemoto T, Ozawa E, Shioji K, Yamaguchi A, Okuzono T, Morikawa I, Hisai H, Fujita K, Goto T, Shirahata N, Iwata Y, Okabe Y, Hara K, Hashimoto Y, Kuwatani M, Isayama H, Fujimoro N, MasamuneA, Hatamaru K, Shimokawa T, Okazaki K, Takeyama Y, Yamaue H, Committee of Clinical Research, Japan Pancreas Society
    Dig Endosc 2022
  2. Gastrojejunostomy versus endoscopic duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer: a propensity score-matched analysis
    Tamura T, Takenaka M, Terai T, Ogura T, Tani M, Shimokawa T, Kitahata Y, Matsumoto I, Mitoro A, Asakuma M, Inatomi O, Omoto S, Sho M; Ueno S, Maehira H, Kitano M
    Surg Endosc 2022
  3. Comparison of infectious complications after spleen preservation versus splenectomy during laparoscopic distal pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter, propensity score-matched analysis
    Lee W, Hwang DW, Han HS, Han IW, Heo JS, Unno M, Ishida M, Tajima H, Nishizawa N, Nakata K, Seyama Y, Ishikawa Y, Hwang HK, Jang JY, Hong T, Park JS, Kim HJ, Jeong CY, Park JI, Matsumoto I, Yamaue H, Kawai M, Ohtsuka M, Mizuno S, Asakuma M, Doejima Y, Hirashita T, Sho M, Takeda Y, Park JI, Kim YH, Kim HJ, Yamaue H, Yamamoto M, Endo I, Nakamura M, Yoon YS
    J Hepatobiliary Pancreat Sci 2022
  4. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplation for advanced biliary tract cancer (KHBO1401-MITSUBA)
    Ioka T, Kanai M, Kobayashi S, sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shido Y, Yoshmura K, Hatano E, Nagano H, Kansai Hepatobiliary Oncology Group (KHBO)
    J Hepatobiliary Pancreat Sci 2022
  5. Short- and long-term outcomes of laparoscopic versus open repeat liver resection for hepatocellular carcinoma: A multicenter study
    Nomi T, Kaibori M, Tanaka S, Hirokawa F, Hokuto D, Noda T, Ueno M, Nakai T, Ikoma H, Iida H, Matsui K, Komeda K, Hayami S, Eguchi H, Matsumoto M, Morimura R, Maehira H, Yoshikawa T, Kubo S
    J Hepatobiliary Pancreat Sci 2022
  6. Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study
    Tanaka S, Noda T, Komeda K, Kosaka H, Iida H, Ueno M, Hokuto D, Ikoma H, Nakai T, Kabata D, Shinkawa H, Kobayashi S, Hirokawa F, Mori H, Hayami S, Morimura R, Matsumoto M, Ishizawa T, Kubo S, Kaibori M
    J Gastrointest Surg 2022
  7. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study
    Hirokawa F, Ueno M, Nakai T, Kaibori M, Nomi T, Iida H, Tanaka S, Komeda K, Hayami S, Kosaka H, Hokuto D, Kubo S, Uchiyama K
    J Gastrointest Surg 26:772-781, 2022
  8. Impact of laparoscopic parenchyma-sparing resection of lesions in the right posterosuperior liver segments on surgical outcomes: A multicenter study based on propensity score analysis
    Shinkawa H, Hirokawa F, Kaibori M, Kabata D, Nomi T, Ueno M, Ikoma H, Nakai T, Iida H, Tanaka S, Komeda K, Kosaka H, Hokuto D, Hayami S, Morimura R, Matsumoto M, Maehira H, Takemura S, Kubo S
    Surgery 171:1311-1319, 2022
  9. Longitudinal pancreaticojejunostomy for pancreaticodigestive tract anastomotic stricture after pancreaticoduodenectomy
    Matsumoto I, Kamei K, Kawaguchi K, Yoshida Y, Matsumoto M, Lee D, Murase T, Satoi S, Takebe A, Takeyama Y
    Ann of Gastroenterol Surg 6:412-419, 2022
  10. Risk factors for and management of morbidity in pure laparoscopic resection of the right posterosuperior segments of the liver: A multicenter retrospective study.
    Shinkawa H, Hirokawa F, Kaibori M, Nomi T, Ueno M, Ikoma H, Nakai T, Iida H, Tanaka S, Komeda K, Kosaka H, Hokuto D, Hayami S, Morimura R, Matsumoto M, Maehira H, Takemura S, Kubo S
    Asian J Endosc Surg 15:539-546, 2022
  11. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma
    Iida H, Tani M, Komeda K, Nomi T, Matsushima H, Tanaka S, Ueno M, Nakai T, Maehira H, Mori H, Matsui K, Hirokawa F, Kaibori M, Kubo S
    HPB (Oxford) 24:101-115, 2022
  12. Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure
    Hirokawa F, Ueno M, Nakai T, Kaibori M, Nomi T, Iida H, Tanaka S, Komeda K, Hayami S, Kosaka H, Hokuto D, Kubo S, Uchiyama K
    Langenbecks Arch Surg 407:699-706, 2022
  13. Three-year observational of glucose metabolism after pancreaticoduodenectomy: A single-center prospective study in Japan
    Niwano F, Babaya N, Hiromine Y, Matsumoto I, Kamei K, Taketomo Y, Yoshida S, Takeyama Y, Noso S, Ikegami H
    J Clin Endocrinol Metab. 107:3362-3369, 2022
  14. Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study
    Hashimoto D, Satoi S, Ishikawa H, Kodera Y, Kamei K, Hirano S, Fujii T, Uemura K, Tsuchida A, Yamada S, Yamamoto T, Hirota K, Sekimoto M
    Trials 23:135, 2022
  15. Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan
    Suto H, Kamei K, Kato H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Ohtsuka M, Rikiyama T, Sudo T, Matsumoto I, Hirao T, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y
    Surgery 172:962-967, 2022
  16. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma
    Asakura Y, Toyama H, Ishida J, Asari S, Terai S, Shirakawa S, Yamashita H, Shimizu T, Ogura Y, Matsumoto I, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Yanagimoto H, Kido M, Ajiki T, Fukumoto T
    Asian J Surg 46:207-212, 2022
  17. Invited Editorial: Comprehensive analysis of molecular biological characteristics of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm
    Matsumoto I
    Ann Surg Oncol 29:4683-4685, 2022
  18. Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of portal vein invasion by pancreatic cancer
    Nakai A, Kamata K, Hyodo T, Chikugo T, Hara A, Otsuka Y, Tanaka H, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Omoto S, Minaga K, Yamao K, Takenaka M, Chiba Y, Watanabe T, Matsumoto I, Takeyama Y, Kudo M
    Endoscopic Ultrasound 11:401-406, 2022
  19. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study
    Hirokawa F, Ueno M, Nakai T, Kaibori M, Nomi T, Iida H, Tanaka S, Komeda K, Hayami S, Kosaka H, Hokuto D, Kubo S, Uchiyama K
    J Gastrointest Surg 26:772-781, 2022
  20. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan
    Tomoko Yoshimoto-Haramura T, Hidaka M, Hasegawa K, Suzumura K, Takemura N, Hama N, Mizuno T, Nomi T, Kobayashi T, Sano K, Yokomizo H, Nitta H, Kurata M, Hasegawa Y, Nagayama M, Tani M, Fukumoto T, Ohta M, Hayashi H, Taniguchi H, Ishino S, Aihara T, Murase T, Tsuchida A, Shimamura T, Marubashi S, Kaneko J, Hara T, Matsushima H, Soyama A, Endo T, Eguchi S
    J Hepatobiliary Pancreat Sci 29:385-393, 2022
  21. Utility of contrast-enhanced harmonic endoscopic ultrasonography for T-staging of patients with extrahepatic bile duct cancer
    Otsuka Y, Kamata K, Hyodo T, Chikugo T, Hara A, Tanaka H, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Yamao K, Takenaka M, Chiba Y, Watanabe T, Nakai T, Matsumoto I, Takeyama Y, Kudo M
    Surg Endosc 36:3254-3260, 2022
  22. Efficacy of slow firing method using reinforced triple-row stapler in preventing postoperative pancreatic fistula during laparoscopic distal pancreatectomy
    Matsumoto I, Kamei K, Satoi S, Murase T, Matsumoto M, Kawaguchi K, Yoshida Y, Lee D, Takebe A, Nakai T, Takeyama Y
    Surgery Today 52:260-267, 2022
  23. Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan.
    Kato H, Kamei K, Suto H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Ohtsuka M, Rikiyama T, Sudo T, Matsumoto I, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y
    J Hepatobiliary Pancreat Sci 29:428-438, 2022
  24. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020
    Okazaki K, Kawa S, Kamisawa T, Ikeura T, Itoi T, Ito T, Inui K, Irisawa A, Uchida K, Ohara H, Kubota K, Kodama Y, Shimuzu K, Tonozuka R, Nakazawa T, Nishino T, Notohara K, Fujinaga Y, Masamune A, Yamamoto H, Watanabe T, Nishiyama T, Kawano M, Shiratori K, Shimosegawa T, Takeyama Y, Members of the Research Committee for IgG4-related Disease supported by Ministry of Health, Labour, Welfare of Japan, Japan Pancreas Society
    J Gastroenterol 57:225-245, 2022
  25. Evidence-based clinical practice guidelines for chronic pancreatitis 2021
    Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, kannno A, Kida M, Sakagami J, Sata N, Takeyama Y, tahara J, Hirota M, Fujimori N, Masamune A, Mochida S, Enomoto N, Shimosegawa T, Koike K
    J Gastroenterol 57:709-724, 2022
  26. Clinical outcomes of organ-preserving pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter nationwide survey in Japan
    Asano Y, Kato H, Arakawa S, Ito M, Nakagawa T, Nakao A, Ohta T, Yamaue H, Yamamoto M, Satoi S, Kodera Y, Takeyama Y, Ohtsuka M, Endo I, Takada T, Horiguchi A
    J Hepatobiliary Pancreat Sci 29:898-910, 2022
  27. JPN clinical practice guidelines 2021 with easy-to-understand explanations for the management of acute pancreatitis
    Takada T, Isaji S, Mayumi T, Yoshida M, Takeyama Y, Itoi T, Sano K, Iizawa, Masamune A, Hirota M, Okamoto K, Inoue D, Kitamura N, Mori Y, Mukai S, Kiriyama S, Shirai K, Tsuchiya A, Higuchi R, Hirashita T
    J Hepatobiliary Pancreat Sci 29:1057-1083, 2022

2021

  1. Influence of the retrocolic versus antecolic route for alimentary tract reconstruction on delayed gastric emptying after pancreatoduodenectomy: A multicenter, noninferiority randomized controlled trial
    Toyama H, Matsumoto I, Mizumoto T, Fujita H, Tsuchida S, Kanbara Y, Kadowaki Y, Maeda H, Okano K, Fukuoka M, Takase S, Shirakawa S, Terai S, Mukubo H, Ishida J, Yamashita H, Ueno K, Tanaka M, Kido M, Ajiki T, Murakami S, Nishimura K, Fukumoto T
    Ann Surg 274:935-944, 2021
  2. Conversion to open laparotomy during laparoscopic distal pancreatectomy: Lessons from a single-center experience in 70 consecutive patients
    Matsumoto I, Kamei K, Satoi S, Murase T, Matsumoto M, Kawaguchi K, Yoshida Y, Lee D, Takebe A, Nakai T, Takeyama Y
    Surgery Today 51:70-78, 2021
  3. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms
    Ishikawa R, Kamata K, Hara A, Tanaka H, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Yamao K, Takenaka M, Minami Y, Watanabe T, Chiba Y, Chikugo T, Matsumoto I, Matsukubo Y, Hyodo T, Kudo M
    Dig Endosc 33:829-839, 2021
  4. Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: Initial clinical results
    Lee D, Komatsu S, Terashima K, Toyama H, Matsuo Y, Takahashi D, Suga M, Nishimura N, Tai K, Kido M, Demizu Y, Tokumaru S, Okimoto T, Sasaki R, Fukumoto T
    Radiat Oncology 16:3, 2021
  5. Improved liver metastasis detection using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video)
    Minaga K, Kitano M, Nakai A, Omoto S, Kamata K, Yamao K, Takenaka M, Tsurusaki M, Chikugo T, Matsumoto I, Chiba Y, Watanabe T, Kudo M
    Gastrointest Endosc 93:433-441, 2021
  6. Glucose metabolism after pancreatectomy: opposite extremes between pancreaticoduodenectomy and distal pancreatectomy
    Niwano F, Babaya N, Hiromine Y, Matsumoto I, Kamei K, Noso S, Takemoto Y, Takeyama Y, Kawabata Y, Ikegami H
    J Clin Endocrinol Metab 106: e2203-e2214, 2021
  7. Safety of combined division vs separate divison of the splenic vein in patients undergoing distal pancreatectomy A noninferiority randomized clinical trial
    Yamada S, Fujii T, Sonohara F, Kawai M, Shibuya K, Matsumoto I, Fukuzawa K, Baba H, Aoki T, Unno M, Satoi S, Kishi Y, Hatano E, Uemura K, Horiguchi A, Sho M, Takeda Y, Shimokawa T, Kodera Y, Yamaue H
    JAMA Surgery 156:418-428, 2021
  8. Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study
    Kim HS, Song W, Choo W, Lee S, Han Y, Bassi C, Salvia R, Marchegiani G, Wolfgang CL, He J, Blair AB, Kluger MD, Su GH, Kim SC, Song KB, Yamamoto M, Hatori T, Yang CY, Yamaue H, Hirono S, Satoi S, Fujii T, Hirano S, Lou W, Hashimoto Y, Shimizu Y, Del Chiaro M, Valente R, Lohr M, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Shyr YM, Wang SE, Han HS, Yoon YS, Besselink MG, van Huijgevoort NCM, Sho M, Nagano H, Kim SG, Honda G, Yang Y, Yu HC, Do Yang J, Chung JC, Nagakawa Y, Seo HI, Lee S, Kim H, Kwon W, Park T, Jang JY
    J Hepatobiliary Pancreat Sci 2021
  9. Diabetic control and nutritional status up to one year after total pancreatectomy: a nationwide multicentre prospective study
    Suto H, Kamei K, Kato H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Takano S, Rikiyama T, Sudo T, Matsumoto I, Hirao T, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y,
    Br J Surg 108: e237-e-238, 2021
  10. Should contrast-enhanced harmonic endoscopic ultrasound be incorporated into the international consensus guidelines to determine the appropriate treatment of intraductal papillary mucinous neoplasm
    Yamazaki T, Takenaka M, Omoto S, Yoshikawa T, Ishikawa R, Okamoto A, Nakai A, Minaga K, Kamata K, Matsumoto I, Takeyama Y, Chikugo T, Chiba Y, Kudo M
    J Clin Med 10:1818, 2021
  11. Glucose Tolerance after Pancreatectomy: A Prospective Observational Follow-Up Study of Pancreaticoduodenectomy and Distal Pancreatectomy
    Ishida J, Toyama H, Matsumoto I, Shirakawa S, Terai S, Yamashita H, Yanagimoto H, Asari S, Kido M, Fukumoto T
    J Am Coll Surg 233:753-762, 2021
  12. ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial
    Okada KI, Kawai M, Hirono S, Sho M, Tani M, Matsumoto I, Yamada S, Amano R, Toyama H, Yamashita Y, Gocho T, Shibuya K, Nagai M, Maehira H, Kamei K, Ohira G, Shirai Y, Takami H, Kimura N, Fukumoto T, Baba H, Kodera Y, Nakao A, Shimokawa T, Katsuda M, Yamaue H
    Trials 22:633, 2021
  13. JNETS Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms: Diagnosis, Treatment, and Follow-up: A Synopsis
    Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S
    J Gastroenterol 56:1033-1044, 2021
  14. Preoperative risk assessment for delirium after hepatic resection in the elderly: a prospective multicenter study
    Ishihara A, Tanaka S, Ueno M, Iida H, Kaibori M, Nomi T, Hirokawa F, Ikoma H, Nakai T, Eguchi H, Shinkawa H, Hayami S, Maehira H, Shibata T, Kubo S
    J Gastrointest Surg 25:134-144, 2021
  15. Preoperative Risk Assessment for Loss of Independence Following Hepatic Resection in Elderly Patients: A Prospective Multicenter Study.
    Tanaka S, Iida H, Ueno M, Hirokawa F, Nomi T, Nakai T, Kaibori M, Ikoma H, Eguchi H, Shinkawa H, Maehira H, Hayami S, Kubo S.
    Ann Surg 274:e253-e261, 2021
  16. Risk factors for incisional hernia according to different wound sites after open hepatectomy using combinations of vertical and horizontal incisions: A multicenter cohort study.
    Iida H, Tani M, Hirokawa F, Ueno M, Noda T, Takemura S, Nomi T, Nakai T, Kaibori M, Kubo S.
    Ann Gastroenterol Surg 5:701-710, 2021
  17. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study.
    Ueno M, Komeda K, Kosaka H, Nakai T, Nomi T, Iida H, Tanaka S, Ikoma H, Matsuda K, Hirokawa F, Matsumoto M, Hokuto D, Mori H, Morimura R, Kaibori M, Yamaue H, Kubo S.
    Int J Surg 2021

2020

  1. NF1 and KRAS mutation in pancreatic cancer secondary to alcoholic chronic pancreatitis
    Murase T, Sakai K, Satou T, Nishio K, Takeyama Y
    Acta Medica Kindai University 45:21-29, 2020
  2. Surgical treatment for chronic pancreatitis: a single-center retrospective study in Japan
    Matsumoto I, Kamei K, Murase T, Yoshida Y, Kawaguchi K, Matsumoto M, Satoi S, Takebe A, Nakai T, Takeyama Y
    J Hepatobiliary Pancreat Sci 27:632-639, 2020
  3. Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: a large prospective, multicenter Japan-Taiwan collaboration study
    Hirono S, Shimokawa T, Nagakawa Y, Shyr YM, Kawai M, Matsumoto I, Satoi S, Yoshitomi H, Okabayashi T, Motoi F, Amano R, Murakami Y, Hirano S, Kawamoto M, Nakamori S, Shan YS, Kobayashi S, Nitta H, Matsukawa H, Uchiyama K, Hsu CP, Kitami C, Yamamoto M, Hwang TL, Yamaue H
    J Hepatobiliary Pancreat Sci 27:622-631, 2020
  4. Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning
    Kang JS, Lee C, Song W, Choo W, Lee S, Lee S, Han Y, Bassi C, Salvia R, Marchegiani G, Wolfgang CL, He J, Blair AB, Kluger MD, Su GH, Kim SC, Song KB, Yamamoto M, Higuchi R, Hatori T, Yang CY, Yamaue H, Hirono S, Satoi S, Fujii T, Hirano S, Lou W, Hashimoto Y, Shimizu Y, Del Chiaro M, Valente R, Lohr M, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Shyr YM, Wang SE, Han HS, Yoon YS, Besselink MG, van Huijgevoort NCM, Sho M, Nagano H, Kim SG, Honda G, Yang Y, Yu HC, Do Yang J, Chung JC, Nagakawa Y, Seo HI, Choi YJ, Byun Y, Kim H, Kwon W, Park T, Jang JY
    Sci Rep 18;10(1):20140, 2020
  5. Pancreatic neuroendocrine tumor with stenosis of the main pancreatic duct leading to pancreatic pleural effusion: a case report
    Yoshida Y, Matsumoto I, Tanaka T, Yamao K, Hayashi A, Kamei K, Satoi S, Takebe A, Nakai T, Takenaka M, Takeyama Y
    Surg Case Rep 25;6(1):222, 2020
  6. Efficacy of Recombinant Human-Soluble Thrombomodulin for Severe Acute Pancreatitis in a Rat Experimental Model
    Matsumoto M, Kamei K, Chikugo T, Matsumoto I, Kawaguchi K, Takeyama Y
    Pancreas 49:503-508, 2020
  7. A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y, Nakamura Y, Hashida K, Honda G, Furukawa K, Toyoda E, Tanabe M, Gotohda N, Matsumoto I, Ryu T, Uyama I, Kojima T, Unno M, Ichikawa D, Inoue Y, Matsukawa H, Sudo T, Takaori K, Yamaue H, Eguchi S, Tahara M, Shinzeki M, Eguchi H, Kurata M, Morimoto M, Hayashi H, Marubashi S, Inomata M, Kimura K, Amaya K, Sho M, Yoshida R, Murata A, Yoshitomi H, Hakamada K, Yasunaga M, Abe N, Hioki M, Tsuchiya M, Misawa T, Seyama Y, Noshiro H, Sakamoto E, Hasegawa K, Kawabata Y, Uchida Y, Kameyama S, Ko S, Takao T, Kitahara K, Nakahira S, Baba H, Watanabe M, Yamamoto M, Nakamura M J Hepatobiliary Pancreat Sci 27:47-55, 2020
  8. Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: A multi-center preoperative score-based analysis. Nomi T, Hirokawa F, Kaibori M, Ueno M, Tanaka S, Hokuto D, Noda T, Nakai T, Matsumoto M, Morimura R, Maehira H, Sho M, Kubo S. Surg Endosc 34:658-666, 2020
  9. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implication from patterns of response and recurrence.
    Kamei K, Shindoh J, Kiya Y, Matsumoto I, Hashimoto M, Takeyama Y
    Clin J Gastroenterol 13(2):240-246, 2020
  10. Partial pancreatic parenchymal atrophy is a new specific finding to diagnose small pancreatic cancer (≤ 10mm) including carcinoma in situ: Comparison with localized benign main pancreatic duct stenosis patients
    Yamao K, Takenaka M, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Matsumoto I, Takeyama Y, Numoto I, Tsurusaki M, Chikugo T, Chiba Y, Watanabe T, Kudo M
    Diagnostics 10:445, 2020
  11. A new monitoring tool CLIP test for progression of oxaliplatin-induced peripheral neropathy: A multicenter prospective study
    Kamei K, Onishi T, Nakata K, Danno K, Ohkawa A, Miyake Y, Okazaki S, Fukunaga M, Hamada T, Shindoh J, Kanagawa A
    Asia Pac J Clin Oncol 16:e257-e262, 2020
  12. FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan
    Kobayashi N, Omae K, Horita Y, Ueno H, Mizuno N, Uesugi K, Sudo K, Ozaka M, Hayashi H, Okanao N, Kamei K, Yamaguchi A, Kobayashi S, Suzuki S, Ishihara S, Uchiyama T, Todaka A, Fukutomi A
    Pancreatology 20:1519-1525, 2020
  13. FOLFIRINOX for recurrent pancreatic cancer after pancreatic resection: A secondary analysis of the nationwide multicenter observational study conducted by the Japan Adjuvant Study Group of Pancreatic Cancer 06
    Morinaga S, Takita M, Yoshizawa A, Kamei K, Nakamori S, Ishihara S, Kuramochi H, Yokoyama Y, Uchiyama T, Murohisa G, Ishigaki M, Todaka A, Fukutomi A
    Pancreas 49:1372-1377, 2020
  14. Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-center propensity score-based analysis
    Nomi T, Hirokawa F, Kaibori M, Ueno M, Tanaka S, Hokuto D, Noda T, Nakai T, Ikoma H, Iida H, Komeda K, Ishizaki M, Hayami S, Eguchi H, Matsumoto M, Morimura R, Maehira H, Sho S, KuboS
    Surg Endosc 34:658-666, 2020
  15. New hepatic resection criteria for intermediate-stage hepatocellular carcinoma can improve lomg-term survival: a retrospective, multicenter collaborative study
    Iida H, Kaibori M, Hirokawa F, Inoue Y, Ueno M, Matsui K, Ishizaki M, Tanaka S, Takemura S, Nomi T, Hokutou D, Noda T, Eguchi H, Nakai T, Maehira H, Mori H, Tani M, Kubo S
    Asian Pac J Cancer Prev 21:2903-2911, 2020
  16. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016
    Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K, Collaborators
    J Gastroenterol 55:462-470, 2020
  17. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesylate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial
    Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K
    J Gastroenterol 55:342-352, 2020
  18. Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019
    Masamune A, kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K, Japan Pancreas Society
    J Gastroenterol 55:1062-1071, 2020

2019

  1. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesylate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K. J Gastroenterol 55:342-352, 2019
  2. Transpancreatic mattress suture with Vicryl mesh around the stump decreases postoperative pancreatic fistula after distal pancreatectomy Yoshida Y, Matsumoto I, Matsumoto M, Kawaguchi K, Murase T, Kamei K, Satoi S, Takebe A, Nakai T, Takeyama Y J Hepatobiliary Pancreat Sci 26:510-516, 2019
  3. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predicts a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients Aoki S, Murakami Y, Sho M, Honda G, Uemura K, Okada K, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M BMC Cancer 19:252, 2019
  4. A prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major heapatectomy for biliary tract cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T, Kansai Hepato-Biliary Oncology (KHBO) Group. Ann Surg 270: 230-237, 2019
  5. The impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX Shirasu H, Todaka A, Omae H, Fujii H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Kobayashi M, Fukutomi A. Cancer Sci 110: 707-716, 2019
  6. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05) Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno. The Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP). Jpn J Clin Oncol 49: 190-194, 2019
  7. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study. Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, Sho M, Tsuchida A, Unno M, For the Study Group of Preoperative therapy for Pancreatic cancer (PREP) J Gastroenterol 54: 194-203, 2019
  8. Sustained elevation of postoperative serum level of carbohydrate antigen 19-9 is high-risk stigmata for primary hepatic recurrence in patients with curatively resected pancreatic adenocarcinoma. Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS) World J Surg 43: 634-641, 2019
  9. Laparoscopic versus open distal pancreatectomy for benign and low-grade malignant lesions of the pancreas: a single-center comparative study. Matsumoto I, Kamei K, Satoi S, Murase T, Matsumoto M, Kawaguchi K, Yoshida Y, Iwasaki T, Takebe A, Nakai T, Takeyama Y. Surgery Today 49: 394-400, 2019
  10. FOLFIRINOX for locally advanced pancreatic cancer: results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan. Matsumoto I, Kamei K, Omae K, Suzuki S, Matsuoka H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi M, Todaka A, Fukutomi A Pancreatology 19: 296-301, 2019
  11. Laparoscopic distal pancreatectomy for elderly patients. Matsumoto I, Kamei K, Takebe A, Takeyama Y. Laparosc Surg 3:13, 2019
  12. Identification of aberrant subvesical bile duct by using intraoperative fuluorescent cholangiography: A case report Iwasaki T, Takeyama Y, Yoshida Y, Kawaguchi, Matsumoto M, Murase T, Kamei K, Takebe A, Matsumoto I, Nakai T Int J Surg Case Rep 61:115-118, 2019
  13. A synonymous VHL variation in exon 2 confuse susceptibility to familial phenochromocytoma and Von Hippel-Lindau Disease. Flores K, Cheng Z, Jasper AM, Natori K, Okamoto T, Tanabe A, Gotoh K, Shibata H, Sakurai A, Nakai T, Wang X, Zethoven M, Balachander S, Aita Y, Young W, Zheng S, Takekoshi K, Nakamura E, Tothill RW, Aruiar RCT, Patricia LM, Dahia PLM. J Clin Endocrinol Metab 104: 3826-3834, 2019
  14. POGLUT1, the putative effector gene driven by rs22993370 in primary biliary cholamgitis susceptibility locus chromosome 3q13.33. Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M. Sci Rep 14: 102, 2019
  15. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. World J Gastroenterol. 7: 107-117, 2019
  16. Effects of oral morphine on dyspnea in patients with cancer: Response rate predictive factors, and clinically meaningful change (CJLSG1101). Takahashi K, Kondo M, Ando M, Shiraki A, Nakashima H, Wakayama H, Kataoka K, Yamamoto M, Sugino Y, Nishikawa M, Imaizumi K, Kojima E, Sumida A, Takeyama Y, Saito H, Hasegawa Y. Oncologist 24: e583-e589, 2019
  17. IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment. Morihara D, Ko YL, Shibata K, Yamauchi R, Fukuda H, Tsuchiya N, Fukunaga A, Kunimoto H, Iwashita H, Takata K, Tanaka T, Sakurai K, Inomata S, Yokoyama K, Nishizawa S, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. J Gastroenterol Hepatol. 34: 2019-2027, 2019
  18. Changes in the serum hepcidin-to-ferritin ratio with erythroferrone after hepatitis C virus eradication using direct-acting antiviral agents. Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. Intern Med. 58: 2915-2922, 2019
  19. Prispective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria. Masamune A, Nabeshima T, Kikuta K, Hamada S, Nakano E, Kume K, Kanno A, Sato A, Tachibana Y, Inatomi O, Yamamoto S, Ikeura T, Futagami S, Taguchi M, Hanada K, Shimizu K, Kageoka M, Saito T, Eguchi T, Kubota K, Takenaka M, Mima A, Irisawa A, Ito T, Andoh A, Inui K, Takeyama Y, Yamaue H, Okazaki K, Shimosegawa T. J Gastroenterol 54: 928-935, 2019
  20. Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature. Odagiri A, Yamaoka A, Miyata K, Bunya N, Kasai T, Takeyama Y, Uemura S, Mikami T, Narimatsu E. 6: 316-320, 2019

2018

  1. Nationwide multicenter observantional study of FOLFIRINOX chemotherapy in 399 patients with unresectable or recurrent pancreatic cancer in Japan. Todaka A, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Usesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Nakamori S, Yachi Y, Henmi T, Kobayashi M, Boku N, Mori K, Fukutomi A Pancreas 47(5): 631-636, 2018
  2. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.
    Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura K, Matsumoto I, Honda G, Okada K, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y Pancreatology Pancreatology 18(1): 106-113, 2018
  3. Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of fine-needle aspiration for pancreatic adenocarcinoma. Kamata K, Takenaka M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Chikugo T, Chiba Y, Matsumoto I, Takeyama Y, Kudo M. Gastrointest Endosc 87(1): 158-163, 2018
  4. Perioperative allogenic blood transfuseon is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M, Hayashi M, Takemura S, Tanaka S, Nakata Y, Matsui K, Ishizaki M, Hirokawa F, Komeda K, Uchiyama K, Kon M, Doki Y, Mori M. Surg Today 48(1): 73-79, 2018
  5. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions. Kamata K, Takenaka M, Kitano M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Kashida H, Chikugo T, Chiba Y, Nakai T, Takeyama Y, Lisotti A, Fusaroli P, Kudo M. Dig Endosc 30(1): 98-106, 2018
  6. Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes. Niwano F, Hiromine Y, Noso S, Babaya N, Ito H, Yasutake S, Matsumoto I, Takeyama Y, Kawabata Y, Ikegami H. J Diabetes Investig 9:1084-1090, 2018
  7. Management of Pancreatolithiasis: A Nationwide Survey in Japan. Inui K, Masamune A, Igarashi Y, Ohara H, Tazuma S, Sugiyama M, Suzuki Y, Miyoshi H, Yamamoto S, Takeyama Y, Nakano E, Takuma K, Sakagami J, Hayashi K, Kogure A, Ito T, Mukai T, Maetani I, Nagahama M, Serikawa M, Ueki T, Furuya K, Isayama H, Morikawa I, Shigeno M, Mizukami K, Nanashima A, Oana S, Ikehata A, Watanabe N, Hirooka Y, Ogoshi K, Sasaki Y, Iwata Y, Kudo Y, Nakayama A, Nakamura M. Pancreas 47:708-714, 2018
  8. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients. Kubota K, Kamisawa T, Hirano K, Hirooka Y, Uchida K, Ikeura T, Ahiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Okazaki K, Kawa S, Shinosegawa T, Takeyama Y, Chiba T. J Hepatobiliary Pancreat Sci 25:223-230, 2018
  9. Nationwide survey of hereditary pancreatitis in Japan. Masamune A, kikuta K, Hamada S, Nakano E, Kume K, Inui A, Shimizu T, Takeyama Y, Nio M, Shinosegawa T. J gastroenterol 53:152-160, 2018
  10. Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomized phase III Trial (JASPAC 01)
    Hagiwara Y, Ohashi Y, Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T; JASPAC 01 Study Group Eur J Cancer 93:79-88, 2018
  11. Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1,515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery. Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H. Ann Gastroenterol Surg 2:212-219, 2018
  12. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms. Kamata K, Takenaka M, Minaga K, Omoto S, Miyata T, Yamao K, Imai H, Nakai A, Tanaka H, Chiba Y, Watanabe T, Sakurai T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kitano M, Kudo M. Dig Endosc 30:659-666, 2018
  13. Laparoscopic single-site and robotic distal pancreatectomy. Matsumoto I. Laparosc Surg 2:19, 2018
  14. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma. Gon H, Kido M, Tanaka M, Kinishita H, Komatsu S, Tsugawa D, Awazu M, Toyama H, Matsumoto I, Itoh, Fukumoto T. Surgery 2018; 164: 1014-1022
  15. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions. Kamata K, Takenaka M, Kitanao M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Nishida N, Kashida H, Chikugo T, Chiba Y, Nakai T, Takeyama Y, Lisotti A, Fusaroli P, Kudo M, Dig Endosc 30:98-106, 2018
  16. Neurilemmona mimicking a multilocular cystic lesion of the liver. Yoshida A, Yamao K, Takenaka M, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Imai H, Matsumoto I, Takeyama Y, Chikugo T, Kudo M. Intern Med 57: 3377-3380, 2018
  17. Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion surgery. Iida H, Kaibori M, Wada H, Hirokawa F, Nakai T, Kinoshita M, Hayashi M, Eguchi H, Kubo S. Mol Clin Oncol 9: 545-552, 2018
  18. Preoperative assessment of frailty predicts age-related events after hepatic resection: a prospective multicenter study. Tanaka S, Ueno M, Iida H, Nomi T, Hirokawa F, Ikoma H, Nakai T, Eguchi H, Kubo S. J Hepatobiliary Pancreat Sci 25: 377-387, 2018
  19. Clinicopathological features and prognosis of primary GISTs with tumor rupture in the real world. Nishida T, Cho H, Hirota S, Masuzawa T, Chiguchi G, Tsujinaka T; Kinki GIST Study Group: Nakai T et al. Ann Surg Oncol 25: 1961-1967, 2018

2017

  1. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. Kubota K, Kamisawa T, Okazaki K, Kawa S, Hirano K, Hirooka Y, Uchida K, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Shimosegawa T, Takeyama Y, Chiba T. J Gastroenterol 52(8): 955-964, 2017
  2. Nationwide epidemiological survey of early chronic pancreatitis in Japan. Masamune A, Kikuta K, Nabeshima T, Nakano E, Hirota M, Kanno A, Kume K, Hamada S, Ito T, Fujita M, Irisawa A, Nakashima M, Hanada K, Eguchi T, Kato R, Inatomi O, Shirane A, Takeyama Y, Tsuji I, Shimosegawa T; Research Committee of Intractable Pancreatic Diseases in Japan. J Gastroenterol 52(8): 992-1000, 2017
  3. Clinical practice guideline for post-ERCP pancreatitis. Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, Kanno A, Kida M, Miyagawa H, Yamaguchi T, Mayumi T, Takeyama Y, Shimosegawa T. J Gastroenterol 52: 1013-1022, 2017
  4. Primary heaptic adenosquamous carcinoma associated with primary sclerasing cholangitis. Yamao K, Takenaka M, Imai H, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Sakurai T, Watanabe T, Nishida N, Matsumoto I, Takeyama Y, Chikugo T, Kudo M Oncology 93(suppl 1): 76-80, 2017
  5. Detection of high-grade pancreatic intraepithelial neoplasia without morphological changes of the main pancreatic duct over a long period: Importance for close follow-up for confirmation. Yamao K, Takenaka M, Imai H, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Sakurai T, Watanabe T, Nishida N, Matsumoto I, Takeyama Y, Chikugo T, Kudo M Oncology 93(suppl 1): 81-86, 2017
  6. Association between the risk factors for pancreatic ductal adenocarcinoma and those for malignant intraductal papillary mucinous neoplasm. Kamata K, Takenaka M, Nkai A, Omoto S, Miyata T, Minaga K, Matsuda T, Yamao K, Imai H, Chiba Y, Sakurai T, Watanabe T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kudo M Oncology 93(suppl 1): 102-106, 2017
  7. Malignant transformation of hepatocellular adenoma. Kwok WY, Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Kono M, Ueshima K, Komeda Y, Arizumi T, Enoki E, Nakai T, Kumabe T, Nakashima O, Kondo F, Kudo M. Oncology 92(suppl 1): 16-28, 2017
  8. Reinforced staplers for distal pancreastectomy. Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H Langenbecks Arch Surg 402: 1197-1204, 2017
  9. Effect of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival in patients with borderline resectable pancreatic adenocarcinoma: a prospective multicenter phase II trial (NAC-GA Trial). Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, Matsumoto I, Eguchi H, Murakami Y, Yamada S, Doi M, Yamaue H; NAC-GA investigators Oncology 93(5): 343-346, 2017
  10. Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, Kim SC, Song KB, Yamamoto M, Hatori T, Hirono S, Satoi S, Fujii T, Hirano S, Hashimoto Y, Shimizu Y, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Han HS, Yoon YS, Sho M, Nagano H, Honda G, Kim SG, Yu HC, Chung JC, Nagakawa Y, Seo HI, Yamaue H. Ann Surg 266: 1062-1068, 2017
  11. Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic Surgery. Satoi S, Yamamoto T, Yoshitomi H, Motoi F, Kawai M, Fujii T, Wada K, Arimitsu H, Sho M, Matsumoto I, Hirano S, Yanagimoto H, Ohtsuka M, Unno M, Yamaue H, Kon M. J Hepatobiliary Pancreat Sci 24: 501-510, 2017
  12. Hemorrhagic and thromboembolic complications after hepato-billiary-pancreatic surgery in patients receiving antithrombotic therapy. Ishida J, Fukumoto T, Kido M, Matsumoto I, Ajiki T, Kawai H, Hirata K, Ku Y. Dig Surg 34(2): 114-124, 2017
  13. Pancreatic duct involvement in well-differentiated neuroendocrine tumor is an independent poor prognostic factor. Nanno Y, Matsumoto I, Zen Y, Otani K, Uemura J, Toyama H, Asari S, Goto T, Ajiki T, Okano K, Suzuki Y, Takeyama Y, Fukumoto T, Ku Y. Ann Surg Oncol 24(4): 1127-1133, 2017
  14. Baseline plasma chromogranin A levels in patients with well-differentiated neuroendocrine tumors of the pancreas: A potential predictor of postoperative recurrence. Nanno Y, Toyama H, Matsumoto I, Otani K, Asari S, Goto T, Ajiki T, Zen Y, Fukumoto T, Ku Y. Pancreatology 17: 291-294, 2017
  15. Retrospective study of the correlation between pathological tumor size and survival after curative resection of T3 pancreatic adenocarcinoma: Proposal for reclassification of the tumor extending beyond the pancreas based on tumor size. Kurata M, Honda G, Murakami Y, Uemura K, Satoi S, Motoi F, Sho M, Matsumoto I, Kawai M, Yanagimoto H, Fukumoto T, Nagai M, Gosho M, Unno M, Yamaue H, for the Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS) World J Surg 41(11): 2867-2875, 2017
  16. Utility of amplatzer vascular plug with preoperative common hepatic artery embolization for distal pancreatectomy with en bloc celiac axis resection. Toguchi M, Tsurusaki M, Numoto I, Hidaka S, Yamakawa M, Asato N, Im S, Yagyu Y, Matsuki M, Takeyama Y, Murakami T. Cardiovasc Intervent Radiol 40(3): 445-449, 2017
  17. Low incidence of lymph node metastasis after resection of hepatitis virus-related intrahepatic cholangiocarcinoma.
    Iida H, Kaibori M, Tanaka S, Takemura S, Wada H, Hirokawa F, Nakai T, Hayashi M, Eguchi H, Kubo S. World J Surg 41(4): 1082-1088, 2017

2016

  1. Trans-pancreatic mattress suture with Vicrl Mesh around the stump during distal pancreatectomy: A novel technique for preventing postoperative pancreatic fistula. Matsumoto I, Takeyama Y, Kamei K, Satoi S, Nakata Y, Ishikawa H, Murase T, Matsumoto M, Nakai T. J Am Coll Surg 223(2): e1-5, 2016
  2. Pancreaticogastrostomy prevents postoperative pancreatic fistula of portal annular pancreas during pancreaticoduodenectomy. Matsumoto I, Kamei K, Satoi S, Nakai T, Takeyama Y. Int Surg 101: 550-553, 2016
  3. Mucinous cystic neoplasm of the pancreas in a male patient diagnosed by endoscopic ultrasonography. Kamei K, Matsumoto I, Takeyama Y. JOP 17(2): 216, 2016
  4. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T. J Gastroenterol 52(2): 85-92, 2016
  5. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. Miyata T, Kitano M, Omoto S, Kadosaka K, Kamata K, Imai H, Sakamoto H, Nisida N, Harwani Y, Murakami T, Takeyama Y, Chiba Y, Kudo M. World J Gastroenterol 22 (12): 3381-3391, 2016
  6. Utility of Amplatzer vascular plug with preoperative common heaptic artery embolization for distal pancreatectomy with enbloc celiac axisresection. Toguchi M, Tsurusaki M, Numoto I, Hidaka S, Yamakawa M, Asato N, Im S, Yagyu Y, Matsuki M, Takeyama Y, Murakami T. Cardiovasc Intervent Radiol 40: 445-449, 2016
  7. Surgical outcomes for the ruptured hepatocellular carcinoma: multicenter analysis with a case-controlled study. Tanaka S, Kaibori M, Ueno M, Wada H, Hirokawa F, Nakai T, Iida H, Eguchi H, Hayashi M, Kubo S. J Gastroentest Surg 20(12): 2021-2034, 2016
  8. Questionnaire survey on work motivations of gastrointestinal and hepatobiliary pancreatic surgeons enrolled in a Japanese national interdisciplinary program. Kaibori M, Nitta H, Hayashi M, Takemura S, Nagano H, Matsui K, Ikoma H, Nakai T, Yasunaga M, Kido M, Aoki T, Rikiyama T, Sano K, Kudo A, Katagiri S, Otsuka Y, Kuroki T, Nomi T, Yano K, Endo I, Ueno M, Kanazawa A, Terajima H, Ko S, Honda G, Seyama Y, Sunagawa H, Aibara T. J Hepatobiliary Pancreat Sci 23(11): 697-702, 2016
  9. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment. Ueno M, Nakai T, Hayashi M, Hirokawa F, Nagano H, Wada H, Kaibori M, Matsui K, Tanaka S, Yamaue H, Kubo S. Surgery 160(3): 661-670, 2016
  10. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, Ajiki T, Fukumoto T, Ku Y. Surgery Today 46: 583-592, 2016
  11. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumor of the Pancreas). Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptelomos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Ouaïssi M, Sastre B, Spandre M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, Lévy P. Gut 65(2): 305-312, 2016
  12. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts.Kamata K, Kitano M, Omoto S, Kadosaka K, Miyata T, Yamao K, Imai H, Sakamoto H, Harwani Y, Chikugo T, Chiba Y, Matsumoto I, Takeyama Y, Kudo M. Endoscopy 48(1): 35-41, 2016
  13. Anatomical variations of liver blood supply in patients with pancreasticobiliary maljunction. Shinozaki K, Ajiki T, Matsumoto T, Yoshida Y, Murakami S, Okazaki T, Toyama H, Matsumoto I, Fukumoto T, Ku Y. Surg Today 46: 169-175, 2016
  14. Reappraisal of total pancreatectomy in 45 patients with pancreatic ductal adenocarcinoma in the modern era using matched-paired analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan. Satoi S, Murakami Y, Motoi F, Sho M, Matsumoto I, Uemura K, Kawai M, Kurata M, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Kinoshita S, Akahori T, Shinzeki M, Fukumoto T, Hashimoto Y, Hirono S, Yamaue H, Honda G, Kwon M. Pancreas 45(7): 1003-1009, 2016
  15. Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. Sho M, Murakami Y, Kawai M, Motoi F, Satoi S, Matsumoto I, Honda G, Uemura K, Yanagimoto H, Kurata M, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Fukumoto T, Unno M, Yamaue H, Nakajima Y. J Hepatobiliary Pancreat Sci 23(3): 188-197, 2016
  16. The predictive powers of serum α-fetoprotein and Des-γ-carboxy prothrombin for survival varies by tumor size in hepatocellular carcinoma. Tsugawa D, Fukumoto T, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Koyama T, Ku Y. Kobe J Med Sci 61(5): E124-131, 2016
  17. A novel technique for the intraoperative identification of biliary drainage areas in the liver after heaptobiliary resection for perihilar cholangiocarcinoma. Fukumoto T, Urade T, Kido M, Takebe A, Ajiki T, Toyama H, Matsumoto I, Ku Y. J Am Coll Surg 222(5): e31-38, 2016
  18. Recommendation of treatment strategy for postoperative hemorrhage: lessons from a single-center experience in 35 patients. Asari S, Matsumoto I, Toyama H, Yamaguchi M, Okada T, Shinzeki M, Goto T, Ajiki T, Fukumoto T, Ku Y. Pancreatology 16: 454-463, 2016
  19. Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study. Kawai M, Murakami Y, Motoi F, Sho M, Satoi S, Matsumoto I, Honda G, Hirono S, Okada KI, Unno M, Nakajima Y, Uemura K, Kwon AH, Fukumoto T, Kurata M, Yamaue H. Surgery 160(2): 293-305, 2016
  20. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomized, non-inferiority trial (JASPAC 01). Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kaimura O, Imai K, Sata N, Hishimura S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y. JASPAC 01 Study Group Lancet 16; 388 (10041): 248-257, 2016
  21. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy. Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y.
    Pancreatology 16(4): 615-620, 2016
  22. Hemorrhagic and thromboembolic complications after hepato-billiary-pancreatic surgery in patients receiving antithrombotic therapy. Ishida J, Fukumoto T, Kido M, Matsumoto I, Ajiki T, Kawai H, Hirata K, Ku Y. Dig Surg 22; 34(2): 114-124, 2016

2015

  1. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study. Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, Motoi F, Uemura K, Sho M, Satoi S, Honda G, Yamaue H, Unno M, Akahori T, Kwon AH, Kurata M, Ajiki T, Fukumoto T, Ku Y. Pancreatology 15(6): 674-680, 2015
  2. Postoperative serum album level is a marker of incomplete adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Matsumoto I, Tanaka M, Shirakawa S, Shinzeki M, Toyama H, Asari S, Goto T, Yamashita H, Ishida J, Ajiki T, Fukumoto T, Shimokawa M, Ku Y. Ann Surg Oncol 22(7): 2408-2415, 2015
  3. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis. Nakai T, Ishikawa H, Tokoro T, Okuno K. World J Surg 39(6): 1527-1536, 2015
  4. Perioperative management for pancreatoduodenectomy following severe acute pancreatitis in patients with periampullary cancer: our experience with six consecutive cases. Asari S, Matsumoto I, Ajiki T, Shinzeki M, Goto T, Fukumoto T, Ku Y. Surg Today 45(2): 181-188, 2015
  5. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocaricinoma who underwent margin-nefative resection. Satoi S, Murakami M, Motoi F, Uemura K, Kawai M, Kurata M, Sho M, Matsumoto I, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Hashimoto Y, Hirono S, Yamaue H, Honda G, Nagai M, Nakajima Y, Shinzeki M, Fukumoto T, Kwon AH. J Gastrointest Surg 19(1): 6-14, 2015
  6. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients. Sho M, Murakami Y, Motoi F, Satoi S, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Kurata M, Fukumoto T, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Unno M, Yamaue H, Nakajima Y. J Gastroenterol 50(6): 694-702, 2015
  7. Acute graft-versus-host disease following simultaneous pancreas-kidney transplantation: report of a case. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Tanaka M, Shirakawa S, Yamashita H, Ajiki T, Fukumoto T, Ku Y. Surgery Today 45(12): 1567-1571, 2015
  8. Portal or superior mesenteric vein resection in pancreastoduodenectomy for pancreastic head carcinoma. Murakami Y, Satoi S, Motoi F, Sho M, Kawai M, Matsumoto I, Honda G; Multicentre Study Group of Pancreatobiliary Surgery (MSG-PBS). Br J Surg 102(7): 837-846, 2015
  9. Impact of preoperative biliary drainage on long-term survival in resected pancreatic ductal adenocarcinoma: A multicenter observational study. Uemura K, Murakami Y, Saito S, Sho M, Motoi F, Kawai M, Matsumoto I, Honda G, Kurata M, Yanagimoto H, Nishiwada S, Fukumoto T, Unno M, Yamaue H. Ann Surg Oncol 22: S1238-S1246, 2015
  10. National Comprehensive Cancer Network resectability status for pancreatic carcinoma predicts overall survival. Murakami Y, Satoi S, Sho M, Motoi F, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Shinzeki M, Kurata M, Kinoshita S, Yamaue H, Unno M. World J Surg 39(9): 2306-2314, 2015
  11. Do patients with small solitary hepatocellular carcinomas without mascoscopically vascular invasion require anatomic resection? Propensity score analysis. Hirokawa F, Kubo S, Nagano H, Nakai T, Kaibori M, Hayashi M, Tanemura S, Wada H, Nakata Y, Matsui K, Ishizaki M, Uchiyama K. Surgery 157(1): 27-36, 2015
  12. Late-onet bile leakage after heaptic resection. Kaibori M, Shimizu J, Hayashi M, Nakai T, Ishizaki M, Matsui K, Kim YK, Hirokawa F, Nakata Y, Noda T, Dono K, Nozawa A, Kwon M, Uchiyama K, Kubo S. Surgery 157(1): 37-44, 2015

2014

  1. Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. Kogita A, Togashi Y, Sogabe S, Terashima M, De Velssco MA, Sakai K, Fujita Y, Tomida S, Takeyama Y, Okuno K, Nakagawa K, Nishio K. Int J Oncol 45(4): 1430-1436, 2014
  2. A prospective randomized comparison between pylorus- and subtotal stomach-preserving pancreatoduodenectomy on postoperative delayed gastric emptying occurrence and long-term nutritional status. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Suzuki Y, Ku Y. J Surg Oncol 109(7): 690-696, 2014
  3. Evaluation of glucose metabolism after distal pancreatectomy according to the donor criteria of the living donor pancreas transplantation guidelines proposed by the Japanese Pancreas and Islet Transplantation Association. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Ku Y. Transplant Proc 46(3): 958-962, 2014
  4. Functioning graft pancreas with thromboses of splenic and superior mesenteric arteries after simultaneous pancreas-kidney transplantation: A case report. Matsumoto I, Shinzeki M, Asari S, Goto T, Shirakawa S, Ajiki T, Fukumoto T, Ku Y. Transplant Proc. 46(3): 989-991, 2014
  5. Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. Ishikawa H, Imano M, Shiraishi O, Yasuda A, Peng YF, Shinkai M, Yasuda T, Imamoto H, Shiozaki H. Gastric Cancer 17(1): 173-180, 2014
  6. Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case
    Murakami S, Ajiki T, Ueno K, Sawa H, Tsuchida S, Otsubo I, Yoshida Y, Shinozaki K, Okazaki T, Matsumoto I, Fukumoto T, Ku. Surg Today 44(7): 1350-1354, 2014
  7. Contrast-enhanced intraoperative ultrasonic cholangiography for real time biliary navigation in hepatobiliary surgery. Urade T, Fukumoto T, Tanaka M, Kido M, Takebe A, Kuramitsu, Chuma M, Matsumoto I, Ajiki T, Ku Y. J Am Coll Surg 218(2): e43-50, 2014
  8. Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma. Fukumoto T, Tominaga M, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Ku Y. Ann Surg Oncol 21(3): 971-978, 2014
  9. Influence of preoperative anti-cancer therapy on respectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Motoi F, Unno M, Takahashi H, Okada T, Wada K, Sho M, Nagano H, Matsumoto I, Satoi S, Murakami Y, Kishiwada M, Honda G, Kinoshita H, Baba H, Hishinuma S, Kitago M, Tajima H, Shinchi H, Takamori H, Kosuge T, Yamaue H, Takada T. J Hepatobiliary Pancreat Sci 21(2): 148-158, 2014
  10. Two-layer challenge test as an assessment to predict islet graft function. Goto T, Fujino Y, Kanashiro M, Tanioka M, Sakai T, Yoshikawa T, Matsumoto I, Suzuki Y, Ku Y, Kuroda Y. Hepatogastroenterology 61(130): 502-506, 2014
  11. Factors affecting survival after resection of intrahepatic cholangiocaricinoma. Murakami S, Ajiki T, Okazaki T, Ueno K, Kido M, Matsumoto I, Fukumoto T, Ku Y. Surg Today 44(10): 1847-1854, 2014
  12. Short- and Long-term Results of Extended Drainage Procedure for Chronic Pancreatitis: A Retrospective Japanese Single-Center Study. Tanaka M, Matsumoto I, Shinzeki M, Asari S, Goto T, Yamashita H, Ishida J, Ajiki T, Fukumoto T, Ku Y. Kobe J. Med.Sci 20; 60(2): W30-36, 2014
  13. Long-term complications after liver transplantation. Kuramitsu K, Fukumoto T, Iwasaki T, Tominaga M, Matsumoto I, Ajiki T, Ku Y. Transplant Proc 46(3): 797-803, 2014
  14. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Kamata K, Kitano M, Kudo M, Sakamoto H, Kadosaka K, Miyata T, Imai H, Maekawa K, Chikugo T, Kumano M, Hyodo T, Murakami T, Chiba Y, Takeyama Y. Endoscopy 46(1): 22-29, 2014
  15. Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resection. Kaibori M, Kubo S, Nagano H, Hayashi M, Nakai T, Ishizaki M, Uchiyama K, Kwon M. Hepatogastroenterology 61: 2028-2034, 2014
  16. Gastrointestional stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature. Ito Y, Yamamura M, Hirai T, Ishikawa T, Kanda T, Nakai T, Ohkouchi M, Hashikura Y, Isoakai K, Hirota S. Int J Clin Exp Pathol 15: 8024-8031, 2014
  17. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma. Nishida M, Nishimura T, Nakai T, Chishina H, Arizumi T, Yada N, Hagiwara S, Minami Y, Ueshima K, Kudo M. Dig Dis 32: 658-663, 2014
  18. High survival in patients operated for small isolated liver metastases from gastric cancer: a multicenter institutional study. Komeda K, Hayashi M, Kubo S, Nagano H, Nakai T, Kaibori M, Hirokawa F, Kwon AH, Uchiyama K. World J Surg 38: 2692-2697, 2014

2013

  1. A case of adenocarcinoma of the duodenum arising from Brunner's gland. Yasuda T, Kamei K, Araki M, Nakata Y, Ishikawa H, Yamazaki M, Sakamoto H, Kitano M, Nakai T, Takeyama Y. Case Rep Gastroenterol 7: 433-437, 2013
  2. Extraperotpneal fluid collection due to chronic pancreatitis. Yasuda T, Kamei K, Araki M, Nakata Y, Ishikawa H, Yamazaki M, Sakamoto H, Kitano M, Nakai T, Takeyama Y. Case Rep Gastroenterol 7: 322-326, 2013
  3. Unresectable colorectal liver metastases: the safety and efficacy of conversion therapy using hepatic arterial infusion immunochemotherapy with 5-fluorouracil and polyethylene glycol-interferon α-2a. Nakai T, Okuno K, Kitaguchi H, Ishikawa H, Yamasaki M. World J Surg 37(8): 1919-1926, 2013
  4. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. Kaibori M, Kubo S, Nagano H, Hayashi M, Haji S, Nakai T, Ishizaki M, Matsui K, Uenishi T, Takemura S, Wada H, Marubashi S, Komeda K, Hirokawa F, Nakata Y, Uchiyama K, Kwon AH. World J Surg 37(4): 820-828, 2013
  5. Criteria for the diagnosis and severity stratification of acute pancreatitis. Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y. World J Gastroenterol, 19(35), 5798-5805, 2013

2012

  1. Gastrointestinal bleeding as the initial manifestation of pancreatic adenocarcinoma successfully treated by emergency pancreaticoduodenectomy. Kamei K, Yasuda T, Nakata Y, Yamazaki M, Ishikawa H, Nkai T, Takeyama Y. ACTA Med Kinki Univ 37(2): 81-90, 2012
  2. COX-2 expression and the prevalence of regulatory T cells in tumor and non-tumor sites of hepatocellular carcinoma. Nakata Y, Takeyama Y, Haji S, Arai M, Yasuda Y, Nakai T, Okuno K, Shiozaki H. ACTA Med Kinki Univ 37(2): 81-90, 2012

2011

  1. Hepatocellular carcinoma accompanied by hypersplenism: five cases of simultaneous hepatectomy and laparoscopic splenectomy. Nakata Y, Haji S, Yamasaki M, Ishikawa H, Yasuda T, Nakai T, Takeyama Y. Acta Med Kinki Univ 36(2): 81-86, 2011

2010

  1. Significant expression of interleukin-15 in rat experimental severe acute pancreatitis. Kamei K, Yasuda T, Ueda T, Fu Q, Shiozaki H, Ohyanagi H, Takeyama Y. Eur Surg Res 44: 159-169, 2010
  2. Two cases of hepatocellular carcinoma located adjacent to the Glisson's capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube. Nakata Y, Haji S, Ishikawa H, Yasuda T, Nakai T, Takeyama Y, Shiozaki H. Surg Laparosc Endosc PercutanTech 20: 189-192, 2010
  3. Frey procedure for chronic pancreatitis in a child with duodenal atresia and complex pancreaticobiliary disorders. Okuyama H, Kubata A, Takeyama Y, et al. Eur J Pediatr Surg 20(1): 45-47, 2010
  4. In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma. Yasuda C, Sakata S, Kakinoki S, Takayama Y, Ohyanagi H, Shiozaki H. Pathophysiology 17(2): 149-155, 2010
  5. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. Kamei K, Yasuda T, Ueda T, Fu Q, Takeyama Y, Shiozaki H. J Hepatobiliary Pancreat Sci 17(3): 305-312, 2010

2009

  1. Long-term prognosis of acute pancreatitis in Japan. Clinical Gasteroenterol and Hepatol Takeyama Y. 7(11 suppl): S15-17, 2009
  2. Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. World J Gastroenterol 15(43): 5489-5492, 2009
  3. Cystic nonfunctioning pancreatic endocrine neoplasm presenting the communication with main pancreatic duct. Kamei K, Yasuda T, Shinzaki W, Satoi S, Ueda T, Takeyama Y. Dig Surg 26:25-26, 2009
  4. Involvement of osteopontin as a core protein in cholesterol gallstone formation. Ishikawa H, Imano M, Takeyama Y, Shiozaki H, Ohyanagi H. J Hepatobiliary Pancreat Surg 16(2): 197-203. 2009
  5. Utility of new Japanese severity score and indication for special therapies in acute pancreatitis. Ueda T, Takeyama Y, Yasuda T, Kamei K, Satoi S, et al. J Gastroenterol 44(5): 453-9, 2009
  6. Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis. Yasuda T, Ueda T, Kamei K, Shinzaki W, Sawa H, Shinzeki M, Ku Y, Takeyama Y. J Gastroenterol 44(10): 1071-1079, 2009
  7. Early infection to peripancreatic tissue in mild acute pancreatitis: report of a case. Kamei K, Takeyama Y, Yasuda T, Kawasaki M, Ueda T, Ohyanagi H, Shiozaki H. Surg Today 39(12): 1083-1085, 2009
  8. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. J Gastroenterol Hepatol 24(3): 384-390, 2009
  9. Laparoscopic excision of an epidermoid cyst arising from the deep abdominal wall. Ishikawa H, Nakai T, Ueda K, Haji S, Takeyama Y, Ohyanagi H. Surg Laparosc Endosc Percutan Tech 19(5): e221-224, 2009
  10. In situ carcinoma of pancreas diagnosed by EUS-FNA. Sakamoto H, Kitano M, Takeyama Y, Kudo M, et al. Endoscopy 40 (Suppl 2); E15-16, 2009
  11. An immunohistochemical study of osteopontin in hepatolithiasis. Nakai, A, Imano, M, Takeyama, Y, Shiozaki, H, Ohyanagi, H. J Hepatobiliary Pancreat Surg 15(6): 615-621, 2009

このページの最上部へ戻る